Akin Gump Strauss Hauer & Feld has filed papers to lobby for the pharmaceutical industry's trade group, in a renewal of a potentially lucrative relationship.
The law firm previously lobbied for the Pharmaceutical Research and Manufacturers of America, or PhRMA, from 2002 to 2008. The contract was worth $600,000 a year, according to lobbying records, but Akin Gump has not reported any activity on behalf of the group in more than two years.
In the new filing, received by the Senate’s secretary on Friday, Akin Gump said it will be lobbying Congress on “health care and budget issues.” The filing doesn’t say how much the firm is set to receive, but it lists former Rep. Bill Paxon (R-N.Y.), a senior adviser at the firm, as handling the account.
PhRMA has lobbying contracts with several other outside firms, including Arnold & Porter and Elmendorf Ryan. A spokesman for the group declined to comment on the Akin Gump filing. Paxon did not immediately return a message requesting comment.
Updated at 3:27 p.m.